ALT logo

Altimmune (ALT) Revenue

Annual Revenue

$20.00 K
-$406.00 K-95.31%

December 31, 2024

Summary

Performance

1-Year Change

-95.31%

3-Year Change

-99.55%

5-Year Change

-99.66%

15-Year Change

-99.81%

ALT Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.72%
ALT annual revenue is higher than 2.72% of companies in Healthcare sector

Analysts Estimate

$20.00 M
ALT annual revenue is currently -99.90% lower than the consensus analysts' forecast

High & Low

All-time High

$32.91 M
ALT annual revenue is currently -99.94% below its historical high of $32.91 million

3-Year Low

-$68.00 K

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ALT previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ALT next annual earnings announcement has not yet been scheduled

OtherALTprofitabilitymetrics:

Annual EPS

-$1.34
ALT annual earnings per share is -$1.34

Annual Net Income

-$95.06 M
ALT annual net profit is -$95.06 million

Annual Operating Profit

-$103.17 M
ALT annual operating income is -$103.17 million

Annual Gross Profit

-
ALT annual gross profit value is unknown

Quarterly Revenue

$5000.00
$0.000.00%

December 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-86.49%

3-Year Change

-99.85%

5-Year Change

-99.13%

ALT Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

3.76%
ALT quarterly revenue is higher than 3.76% of companies in Healthcare sector

Analysts Estimate

$560.00
ALT quarterly revenue is currently +792.86% higher than the consensus analysts' forecast

High & Low

All-time High

$10.91 M
ALT quarterly revenue is currently -99.95% below its historical high of $10.91 million

3-Year Low

-$110.00 K

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ALT previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ALT next earnings announcement is scheduled for May 9, 2025

Related metrics

Quarterly Gross Profit

-
ALT quarterly gross profit value is unknown

Quarterly Operating Profit

-$24.87 M
ALT quarterly operating income is -$24.87 million

Quarterly Net Income

-$23.18 M
ALT quarterly net profit is -$23.18 million

Quarterly EPS

-$0.33
ALT quarterly earnings per share is -$0.33

TTM Revenue

$20.00 K
-$32.00 K-61.54%

December 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-95.31%

3-Year Change

-99.55%

5-Year Change

-99.66%

ALT TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.88%
ALT TTM revenue is higher than 2.88% of companies in Healthcare sector

Analysts Estimate

$15.56 K
ALT TTM revenue is currently +28.53% higher than the consensus analysts' forecast

High & Low

All-time High

$33.39 M
ALT TTM revenue is currently -99.94% below its historical high of $33.39 million

3-Year Low

-$81.00 K

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ALT previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ALT next earnings announcement is scheduled for May 9, 2025

OtherALTprofitabilitymetrics:

TTM Gross Profit

-
ALT TTM gross profit value is unknown

TTM Operating Profit

-$103.17 M
ALT TTM operating income is -$103.17 million

TTM Net Income

-$95.06 M
ALT TTM net profit is -$95.06 million

TTM EPS

-$1.34
ALT TTM earnings per share is -$1.34

ALT Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-95.3%-86.5%-95.3%
3 y3 years-99.5%-99.8%-99.5%
5 y5 years-99.7%-99.1%-99.7%

ALT Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.5%+129.4%-99.8%+104.5%-99.5%+124.7%
5 y5-year-99.8%+129.4%-99.8%+104.5%-99.8%+124.7%
alltimeall time-99.9%+129.4%-100.0%+104.5%-99.9%+124.7%

Altimmune Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$20.00 K(-95.3%)
-
-
Dec 2024
-
$5000.00(0.0%)
$20.00 K(-61.5%)
Sep 2024
-
$5000.00(0.0%)
$52.00 K(-87.3%)
Jun 2024
-
$5000.00(0.0%)
$409.00 K(-0.2%)
Mar 2024
-
$5000.00(-86.5%)
$410.00 K(-3.8%)
Dec 2023
$426.00 K(-726.5%)
$37.00 K(-89.8%)
$426.00 K(+52.7%)
Sep 2023
-
$362.00 K(+5933.3%)
$279.00 K(-444.4%)
Jun 2023
-
$6000.00(-71.4%)
-$81.00 K(+2.5%)
Mar 2023
-
$21.00 K(-119.1%)
-$79.00 K(+16.2%)
Dec 2022
-$68.00 K(-101.5%)
-$110.00 K(-5600.0%)
-$68.00 K(-102.0%)
Sep 2022
-
$2000.00(-75.0%)
$3.32 M(-4.5%)
Jun 2022
-
$8000.00(-75.0%)
$3.48 M(-3.6%)
Mar 2022
-
$32.00 K(-99.0%)
$3.60 M(-18.3%)
Dec 2021
$4.41 M(-46.1%)
$3.28 M(+1974.1%)
$4.41 M(+28.0%)
Sep 2021
-
$158.00 K(+15.3%)
$3.45 M(-44.7%)
Jun 2021
-
$137.00 K(-83.7%)
$6.23 M(-8.6%)
Mar 2021
-
$838.00 K(-63.8%)
$6.81 M(-16.8%)
Dec 2020
$8.19 M(+41.1%)
$2.31 M(-21.3%)
$8.19 M(+26.9%)
Sep 2020
-
$2.94 M(+307.2%)
$6.45 M(+55.2%)
Jun 2020
-
$721.60 K(-67.4%)
$4.15 M(-17.9%)
Mar 2020
-
$2.21 M(+284.3%)
$5.06 M(-12.8%)
Dec 2019
$5.80 M(-43.8%)
$575.80 K(-10.6%)
$5.80 M(-25.8%)
Sep 2019
-
$644.00 K(-60.4%)
$7.81 M(-20.3%)
Jun 2019
-
$1.63 M(-45.0%)
$9.80 M(-7.5%)
Mar 2019
-
$2.96 M(+14.2%)
$10.60 M(+2.6%)
Dec 2018
$10.33 M(-3.8%)
$2.59 M(-1.7%)
$10.33 M(-44.0%)
Sep 2018
-
$2.63 M(+9.0%)
$18.44 M(+16.5%)
Jun 2018
-
$2.42 M(-10.2%)
$15.84 M(+18.0%)
Mar 2018
-
$2.69 M(-74.9%)
$13.42 M(+25.0%)
Dec 2017
$10.74 M(+2518.5%)
$10.70 M(>+9900.0%)
$10.74 M(+3758.5%)
Sep 2017
-
$26.70 K(+444.9%)
$278.30 K(+8.5%)
Jun 2017
-
$4900.00(0.0%)
$256.50 K(-37.5%)
Mar 2017
-
$4900.00(-98.0%)
$410.10 K(-70.9%)
Dec 2016
$410.10 K(-96.1%)
$241.80 K(+4834.7%)
$1.41 M(-42.1%)
Sep 2016
-
$4900.00(-96.9%)
$2.44 M(-32.1%)
Jun 2016
-
$158.50 K(-84.2%)
$3.59 M(-21.7%)
Mar 2016
-
$1.01 M(-20.6%)
$4.58 M(-57.0%)
Dec 2015
$10.64 M
$1.27 M(+9.6%)
$10.64 M(-5.0%)
Sep 2015
-
$1.16 M(+0.5%)
$11.20 M(+1.8%)
DateAnnualQuarterlyTTM
Jun 2015
-
$1.15 M(-83.7%)
$11.01 M(-18.6%)
Mar 2015
-
$7.07 M(+287.1%)
$13.52 M(+32.6%)
Dec 2014
$10.19 M(-43.1%)
$1.83 M(+89.7%)
$10.19 M(-15.2%)
Sep 2014
-
$962.50 K(-73.7%)
$12.02 M(-17.4%)
Jun 2014
-
$3.66 M(-2.2%)
$14.54 M(-4.2%)
Mar 2014
-
$3.74 M(+2.4%)
$15.18 M(-15.3%)
Dec 2013
$17.91 M(-28.9%)
$3.65 M(+4.8%)
$17.91 M(-11.6%)
Sep 2013
-
$3.49 M(-18.8%)
$20.27 M(-13.7%)
Jun 2013
-
$4.30 M(-33.7%)
$23.48 M(-7.9%)
Mar 2013
-
$6.48 M(+7.7%)
$25.50 M(+1.3%)
Dec 2012
$25.18 M(+3.7%)
$6.01 M(-10.2%)
$25.18 M(-0.9%)
Sep 2012
-
$6.70 M(+6.0%)
$25.40 M(+6.0%)
Jun 2012
-
$6.32 M(+2.7%)
$23.97 M(-0.5%)
Mar 2012
-
$6.15 M(-1.5%)
$24.08 M(-0.8%)
Dec 2011
$24.27 M(+15.6%)
$6.24 M(+18.6%)
$24.27 M(-2.5%)
Sep 2011
-
$5.26 M(-18.2%)
$24.88 M(-3.8%)
Jun 2011
-
$6.43 M(+1.4%)
$25.86 M(+6.8%)
Mar 2011
-
$6.34 M(-7.5%)
$24.21 M(+15.3%)
Dec 2010
$20.99 M(-23.8%)
$6.85 M(+9.8%)
$20.99 M(-1.3%)
Sep 2010
-
$6.24 M(+30.6%)
$21.27 M(-2.7%)
Jun 2010
-
$4.78 M(+53.4%)
$21.85 M(-13.1%)
Mar 2010
-
$3.12 M(-56.3%)
$25.14 M(-8.7%)
Dec 2009
$27.55 M(-16.3%)
$7.13 M(+4.3%)
$27.55 M(+6.4%)
Sep 2009
-
$6.83 M(-15.4%)
$25.90 M(-12.9%)
Jun 2009
-
$8.07 M(+46.2%)
$29.75 M(-8.7%)
Mar 2009
-
$5.52 M(+0.8%)
$32.59 M(-1.0%)
Dec 2008
$32.91 M(+124.7%)
$5.48 M(-48.7%)
$32.91 M(-1.4%)
Sep 2008
-
$10.68 M(-2.2%)
$33.39 M(+28.0%)
Jun 2008
-
$10.91 M(+86.9%)
$26.09 M(+49.7%)
Mar 2008
-
$5.84 M(-2.1%)
$17.42 M(+19.7%)
Dec 2007
$14.64 M(+780.4%)
$5.96 M(+76.8%)
$14.55 M(+44.6%)
Sep 2007
-
$3.37 M(+50.0%)
$10.06 M(+50.4%)
Jun 2007
-
$2.25 M(-24.3%)
$6.69 M(+36.3%)
Mar 2007
-
$2.97 M(+101.2%)
$4.91 M(+109.2%)
Dec 2006
$1.66 M(+183.8%)
$1.48 M(>+9900.0%)
$2.35 M(+87.5%)
Sep 2006
-
$1600.00(-99.7%)
$1.25 M(-14.0%)
Jun 2006
-
$466.00 K(+15.1%)
$1.46 M(+47.0%)
Mar 2006
-
$405.00 K(+6.6%)
$991.10 K(+69.1%)
Dec 2005
$586.10 K
$379.80 K(+84.1%)
$586.10 K(+184.1%)
Sep 2005
-
$206.30 K
$206.30 K

FAQ

  • What is Altimmune annual revenue?
  • What is the all time high annual revenue for Altimmune?
  • What is Altimmune annual revenue year-on-year change?
  • What is Altimmune quarterly revenue?
  • What is the all time high quarterly revenue for Altimmune?
  • What is Altimmune quarterly revenue year-on-year change?
  • What is Altimmune TTM revenue?
  • What is the all time high TTM revenue for Altimmune?
  • What is Altimmune TTM revenue year-on-year change?

What is Altimmune annual revenue?

The current annual revenue of ALT is $20.00 K

What is the all time high annual revenue for Altimmune?

Altimmune all-time high annual revenue is $32.91 M

What is Altimmune annual revenue year-on-year change?

Over the past year, ALT annual revenue has changed by -$406.00 K (-95.31%)

What is Altimmune quarterly revenue?

The current quarterly revenue of ALT is $5000.00

What is the all time high quarterly revenue for Altimmune?

Altimmune all-time high quarterly revenue is $10.91 M

What is Altimmune quarterly revenue year-on-year change?

Over the past year, ALT quarterly revenue has changed by -$32.00 K (-86.49%)

What is Altimmune TTM revenue?

The current TTM revenue of ALT is $20.00 K

What is the all time high TTM revenue for Altimmune?

Altimmune all-time high TTM revenue is $33.39 M

What is Altimmune TTM revenue year-on-year change?

Over the past year, ALT TTM revenue has changed by -$406.00 K (-95.31%)